ropinirole - Compound Summary (CID 5095)
Also known as: ReQuip, ropinirol, Ropinirol [INN-Spanish], Ropinirolum [INN-Latin], Ropinirolum, ReQuip CR, ReQuip XL, 91374-21-9, CHEBI:8888
Molecular Formula: C16H24N2O   Molecular Weight: 260.37456   InChIKey: UHSKFQJFRQCDBE-UHFFFAOYSA-N
Ropinirole is a non-ergoline dopamine agonist, manufactured by GlaxoSmithKline. It is used in the treatment of Parkinson's disease, and is also one of two medications in the United States with an FDA-approved indication for the treatment of restless legs syndrome (the other being Pramipexole). [Wikipedia]   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _